Tech Transfer Pitfalls and Preventive Measures

This guide outlines common pitfalls in the tech transfer process within pharmaceutical and biotech manufacturing, emphasizing the importance of precise knowledge and process transfer as companies move from lab or pilot scale to larger-scale production. It highlights the risks associated with poorly executed tech transfers, including increased costs, product failures, and delays. The document details several inefficiencies encountered by Integrated Project Management Company (IPM) while working with pharma companies and contract manufacturing organizations (CMOs). Key challenges include unclear project scoping, prioritization issues, and lack of cross-functional collaboration. The guide stresses the need for effective communication, defined roles, and robust knowledge management to mitigate these risks. It also discusses the significance of relationship-building between partners and the necessity of consistent, well-defined processes to enhance efficiency and project success. By documenting assumptions and decisions, companies can improve planning and execution in tech transfer projects.